How are Pharmakogenetik Medicheck and Wechseljahre related?

The Pharmakogenetik Medicheck and the Wechseljahre (menopause) test from MyBody-X are separate products with different focuses. The Medicheck analyzes genetic variants affecting drug metabolism (e.g., CYP450 enzymes, VKORC1 for warfarin) to estimate medication tolerability and efficacy. The menopause test addresses hormonal changes during menopause, such as estrogen and progesterone levels, and related symptoms like hot flashes or bloating. No direct scientific link between the two tests is evident from the provided context. However, an indirect relevance exists: menopause alters hormone balance, which can affect the metabolism of certain drugs (e.g., hormone replacement therapy, antidepressants). Pharmacogenetics could potentially help optimize dosing or choice of such medications. Yet this is not a clinical standard; evidence is based on mechanistic reasoning and limited studies. Both tests provide guidance, not diagnoses. Medical supervision is essential, especially for hormone therapies. Evidence: mechanistic/unclear.